Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology, Metabolic Diseases and Inflammation. CrownBio offering includes end-to-end preclinical solutions, a unique collection of ready-to-run, well-validated in vitro and in vivo models, and cutting-edge technologies. Our Translational Platforms enable clients around the world to deliver superior clinical candidates. CrownBio provides preclinical immunotherapy research platforms to support the transition of immunotherapeutics from the lab into the clinic.